Project Number 1R43AG069524-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Formulation of a Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular Contributions to Cognitive Impairment Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) k. Vasculature Researcher and Organization Principal Investigator OSSANNA, NINA Principal Investigator First Name NINA Principal Investigator Last Name OSSANNA Awardee Organization PRONEUROGEN, INC. Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $439,355 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
